Cell-Associated, Heparin-Like Molecules Modulate the Ability of LDL to Regulate PCSK9 Uptake

Journal of Lipid Research - United States
doi 10.1194/jlr.m087189
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

LDL Apheresis or PCSK9 Inhibition? Sometimes We Have to Combine Them

Vessel Plus
2017English

Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors.

Cardiologia Croatica
Cardiovascular MedicineCardiology
2016English

Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A2

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2001English

S-Nitrosylation of ARH Is Required for LDL Uptake by the LDL Receptor

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2013English

Potential of PCSK9 as a New Target for the Management of LDL Cholesterol

Research Reports in Clinical Cardiology
2015English

Effects of Currently Prescribed LDL-C-lowering Drugs on PCSK9 and Implications for the Next Generation of LDL-C-lowering Agents

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2011English

Antioxidants Inhibit the Ability of Lysophosphatidylcholine to Regulate Proteoglycan Synthesis

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2006English

Phenome-Wide Association Analysis of LDL-cholesterol Lowering Genetic Variants in PCSK9

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2019English

Potentiation of Psoriasis-Like Inflammation by PCSK9

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy